Amazing pipeline and an amazing patent portfolio. Have you noticed Arena PR in 2015 stepping up to the plate?
Quit the B.S. please. Your garbage is no longer being developed due to its dangerous side effects.
Yes with combined annual revenue of $10B annually between humira, enbrel, and remicade its no wonder adp334 is number one. Adp334 has potential to become standard of care replacing all others for treatment of anti inflammatory conditions.
You were never long. First time I saw you here was after the 80% run up which happened to attract a lot of bashers.
Check out Arena website under programs and see exactly what you are missing!
DRUG CANDIDATES IN DEVELOPMENT
Drug Candidate Disease Area Target Status Retained Rights
Temanogrel* Thrombotic Diseases 5HT2A Inverse Agonist Phase 1 Multiple-Ascending Dose Trial Ongoing Outside South Korea
ADP811 (Ralinepag) Pulmonary Arterial Hypertension PGI2 Agonist Phase 2 Trial Initiated Worldwide
APD334 Autoimmune Diseases S1P1 Agonist Phase 1 Trial Completed Worldwide
APD371 Pain CB2 Agonist Phase 1 Single-Ascending Dose Trial Ongoing Worldwide
*Development expenses shared with or funded by collaborators
Our proprietary GPCR-based technologies and our validated drug discovery and development capabilities and approach enable us to internally discover and develop drug candidates. We periodically conduct a review of our programs to prioritize the use of our resources, and we are currently focusing our resources and activities on BELVIQ (lorcaserin HCl) and the other clinical-stage programs in the table above, as well as on earlier-stage programs that span several therapeutic areas.
You say ARNA is not worth $6 however Wall Street says it is. Can you stay solvent long enough to be proven right?
Amazing what an 85% gain can do isn't it? Looks like Arena finally listened to investors and got a new PR team onboard.
I deny your motion. Market order to buy 100,000 shares as restitution.
I have been trading this stock for more years than I care to admit but this here run of strength bodes well for longs as something is cooking in the backround for sure. This is not just a simple PI PR people. This is more.
Something else is driving this move, something behind the scenes, there is no doubt. Any dip has been met with huge big block buys.
This is just the 4th quarter people! Oh and don't forget to add ",000" to those sales figures as they are in the billions not millions.
Look in this post for the breakdown in terms of annual dollars in sales for this group of drugs.
What a lying little man. You were buried last week with shorts at $4 and now thru an act of god your average is $5.8. Keep up the bull.